nipradilol has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaishi, M; Handa, S; Mitamura, H; Ogawa, S; Yoshikawa, T | 2 |
2 trial(s) available for nipradilol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Beta-1-selectivity is not essential to achieve therapeutic efficacy with beta-blockade therapy for idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiomyopathy, Dilated; Confounding Factors, Epidemiologic; Coronary Angiography; Electrocardiography; Female; Humans; Lymphocytes; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Ventriculography; Receptors, Adrenergic, beta; Ventricular Function, Left | 1995 |
Effect of a new beta-blocker, nipradilol, on cardiac function and neurohumoral factors in idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Ventricular Function, Left | 1996 |